Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > October/December 2008 - Volume 22 - Issue 4 > The Added Value of Neuropsychologic Tests and Structural Ima...
Text sizing:
A
A
A
Alzheimer Disease & Associated Disorders:
October/December 2008 - Volume 22 - Issue 4 - pp 309-320
doi: 10.1097/WAD.0b013e3181871a47
Original Articles

The Added Value of Neuropsychologic Tests and Structural Imaging for the Etiologic Diagnosis of Dementia in Italian Expert Centers

Geroldi, Cristina MD, PhD; Canu, Elisa PsyD; Bruni, Amalia C. MD; Forno, Gloria Dal MD, PhD; Ferri, Raffaele MD; Gabelli, Carlo MD; Perri, Roberta MD, PhD; Iapaolo, David MD; Scarpino, Osvaldo MD; Sinforiani, Elena MD; Zanetti, Orazio MD; Frisoni, Giovanni B. MD

Collapse Box

Abstract

Aim of the study was to assess the added diagnostic value of neuropsychologic tests and structural neuroimaging (computed tomography or magnetic resonance) in the routine clinical assessment of demented patients in Italian expert centers. Nine centers were involved, located across the whole country (3 in Northern, 3 in Central, and 3 in Southern Italy). Diagnostic pathways were tracked for 474 patients with an expert diagnosis of neurodegenerative or vascular dementia (age 76±8; 62% females; Mini-Mental State Examination 17.70±5.7). The contribution of neuropsychology and structural neuroimaging to diagnosis was estimated as number needed to test (NNT), denoting the number of patients who need to undergo such procedures to improve expert diagnosis of 1 unit. Expert physicians reached their diagnosis without resorting to structural imaging examinations and neuropsychologic tests in 93% of Alzheimer disease (AD) and 76% of non-AD dementias. The completion of the extended assessment led to improvement of diagnostic accuracy in both cases: the NNT was 15.3 (95% confidence interval: 10.4-29.1) and 4.1 (3.0 to 6.5) for AD and non-AD diagnoses. The added value of structural imaging and neuropsychologic testing in the routine clinical assessment of demented patients is substantial in both AD and non-AD cases.

© 2008 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Article Tools

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.